Madrigal Appoints Sanofi's Bill Sibold as CEO

Conshohocken, PA, September 11, 2023 (Globe Newswire) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage biopharmaceutical enterprise dedicated to pioneering novel therapies for nonalcoholic steatohepatitis (NASH), has officially introduced Bill Sibold as the incoming Chief Executive Officer (CEO). Bill Sibold, a distinguished leader, has also assumed a position on Madrigal's esteemed Board of Directors.

Read full article here.